KR20110066201A - 할로겐화 환형 화합물의 합성 방법 - Google Patents

할로겐화 환형 화합물의 합성 방법 Download PDF

Info

Publication number
KR20110066201A
KR20110066201A KR1020117009786A KR20117009786A KR20110066201A KR 20110066201 A KR20110066201 A KR 20110066201A KR 1020117009786 A KR1020117009786 A KR 1020117009786A KR 20117009786 A KR20117009786 A KR 20117009786A KR 20110066201 A KR20110066201 A KR 20110066201A
Authority
KR
South Korea
Prior art keywords
formula
group
alkyl group
compound
adduct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020117009786A
Other languages
English (en)
Korean (ko)
Inventor
막스 브라운
Original Assignee
솔베이(소시에떼아노님)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 솔베이(소시에떼아노님) filed Critical 솔베이(소시에떼아노님)
Publication of KR20110066201A publication Critical patent/KR20110066201A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/803—Processes of preparation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
KR1020117009786A 2008-09-30 2009-09-25 할로겐화 환형 화합물의 합성 방법 Ceased KR20110066201A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08165547 2008-09-30
EP08165547.4 2008-09-30

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020167031136A Division KR20160131129A (ko) 2008-09-30 2009-09-25 할로겐화 환형 화합물의 합성 방법

Publications (1)

Publication Number Publication Date
KR20110066201A true KR20110066201A (ko) 2011-06-16

Family

ID=40351699

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020167031136A Ceased KR20160131129A (ko) 2008-09-30 2009-09-25 할로겐화 환형 화합물의 합성 방법
KR1020117009786A Ceased KR20110066201A (ko) 2008-09-30 2009-09-25 할로겐화 환형 화합물의 합성 방법
KR1020197018768A Ceased KR20190080972A (ko) 2008-09-30 2009-09-25 할로겐화 환형 화합물의 합성 방법

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1020167031136A Ceased KR20160131129A (ko) 2008-09-30 2009-09-25 할로겐화 환형 화합물의 합성 방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020197018768A Ceased KR20190080972A (ko) 2008-09-30 2009-09-25 할로겐화 환형 화합물의 합성 방법

Country Status (7)

Country Link
US (2) US8431710B2 (enExample)
EP (1) EP2334645B1 (enExample)
JP (5) JP6180705B2 (enExample)
KR (3) KR20160131129A (enExample)
CN (2) CN102164898A (enExample)
CA (1) CA2735921C (enExample)
WO (1) WO2010037688A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2310350T3 (en) 2008-07-04 2017-12-11 Solvay PROCEDURE FOR THE PREPARATION OF ALKENONES
KR20160131129A (ko) * 2008-09-30 2016-11-15 솔베이(소시에떼아노님) 할로겐화 환형 화합물의 합성 방법
GB0903749D0 (en) * 2009-03-04 2009-04-15 Syngenta Participations Ag Chemical process
US8957254B2 (en) 2009-07-06 2015-02-17 Solvay Sa Process for chemical synthesis from an alkenone made from a halogenated precursor
PL2451763T3 (pl) 2009-07-06 2015-08-31 Solvay Sposób wytwarzania halogenowanych prekursorów alkenonów w obecności rozpuszczalnika
EP2662359A1 (en) 2012-05-08 2013-11-13 Solvay Sa Ionic Liquids, Method for manufacturing thereof, and Electrochemical Devices Comprising the Same
CN104583167B (zh) * 2012-08-22 2017-09-19 索尔维公司 用于制备烯酮的方法
MY170539A (en) 2012-12-20 2019-08-15 Solvay Salts of n-containing heterocyclic anions as components in electrolytes
MX2015017640A (es) * 2013-06-20 2016-09-07 Basf Se Proceso para preparar compuestos de piridilpirazol y sus derivados de piridilhidrazina.
EP2987782A1 (en) 2014-08-22 2016-02-24 Solvay SA Distillation process comprising at least two distillation steps to obtain purified halogenated carboxylic acid halide, and use of the purified halogenated carboxylic acid halide
WO2016079122A1 (en) 2014-11-17 2016-05-26 Solvay Sa A method for producing a chemical compound and apparatus therefor
CN107001231A (zh) 2014-11-17 2017-08-01 索尔维公司 包括至少两个蒸馏步骤以获得纯化的卤化的羧酸卤化物的蒸馏方法、以及该纯化的卤化的羧酸卤化物的用途
EP3031791A1 (en) 2014-12-10 2016-06-15 Solvay SA Halogenation process of 1,1-dihaloethene
EP3199522A1 (en) 2016-02-01 2017-08-02 Solvay SA Aminothioate derivatives, production thereof and use
WO2019043238A1 (en) 2017-09-04 2019-03-07 Solvay Sa PROCESS AND INTERMEDIARY FOR MANUFACTURING DIFLUOROACETYL CHLORIDE
JP6911143B2 (ja) 2018-11-07 2021-07-28 福建永晶科技股▲ふん▼有限公司Ｆｕｊｉａｎ Ｙｏｎｇｊｉｎｇ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏ．， Ｌｔｄ ピラゾール又はピリミジノンの新しい製造方法
CN120172888A (zh) * 2018-12-27 2025-06-20 科迪华农业科技有限责任公司 磺酰胺除草剂方法中间体的制备
WO2021152055A1 (en) 2020-01-31 2021-08-05 Solvay Sa Process for the manufacture of haloalkyl substituted pyridine compounds
JP2021079146A (ja) * 2021-02-22 2021-05-27 株式会社三洋物産 遊技機
JP7315071B2 (ja) * 2021-03-03 2023-07-26 株式会社三洋物産 遊技機

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3420166A1 (de) * 1984-05-30 1985-12-05 Basf Ag, 6700 Ludwigshafen Pyrimidylphosphorsaeureester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von schaedlingen
BR9205735A (pt) * 1991-03-07 1994-11-08 Du Pont Piridina sulfonamida herbicida.
US5235060A (en) * 1991-07-11 1993-08-10 E. I. Du Pont De Nemours And Company Certain three component ionic substituted pyridine compounds as intermediates for preparation as herbicides
DE4128828A1 (de) 1991-08-30 1993-03-04 Basf Ag Ammonium- oder harnstoffhaltige duengemittel und verfahren zu ihrer herstellung
CA2146930A1 (en) 1992-10-13 1994-04-28 Francis David King Heterocyclic -esters or -amides used as 5-ht4 receptor antagonists
EP0659729B1 (de) 1993-12-23 1998-06-24 Solvay Fluor und Derivate GmbH Verfahren zur Herstellung von Polyfluorchlor- und Perfluorcarbonsäurechloriden unter Chlorzusatz
JP3843152B2 (ja) * 1995-08-08 2006-11-08 石原産業株式会社 ４−アルコキシ−１，１，１−トリフルオロ−３−ブテン−２−オンの製造方法
GB2305174A (en) 1995-09-15 1997-04-02 Zeneca Ltd Chemical process
GB9711114D0 (en) * 1997-05-29 1997-07-23 Merck Sharp & Dohme Therapeutic agents
DE19821088A1 (de) 1998-05-12 1999-11-18 Basf Ag Modifizierte Polykondensate der Asparaginsäure, Verfahren zu ihrer Herstellung und ihre Verwendung in Düngemitteln
WO2002053518A2 (en) 2000-12-29 2002-07-11 Honeywell International, Inc. HALOGENATED-α,β-UNSATURATED-β-(SUBSTITUTED-AMINO) CARBOXYLATE ESTERS
ES2318275T3 (es) 2003-03-07 2009-05-01 Syngenta Participations Ag Procedimiento para la produccion de esteres del acido niocotinico sustituidos.
DE10325715A1 (de) * 2003-06-06 2004-12-23 Solvay Fluor Und Derivate Gmbh Vereinfachte Herstellung von Alkenonen
US20060128702A1 (en) 2004-11-23 2006-06-15 Manojit Pal Heterocyclic and bicyclic compounds, compositions and methods
DE102004061593A1 (de) 2004-12-21 2006-06-22 Abbott Gmbh & Co. Kg Substituierte N-heterocyclische Verbindungen und ihre therapeutische Verwendung
KR20080048502A (ko) 2005-09-29 2008-06-02 머크 앤드 캄파니 인코포레이티드 멜라노코르틴-4 수용체 조절제로서의 아실화스피로피페리딘 유도체
WO2007088876A1 (ja) * 2006-02-02 2007-08-09 Kumiai Chemical Industry Co., Ltd. ピリドン誘導体及び除草剤
US8729059B2 (en) * 2007-02-09 2014-05-20 Emory University Paramyxovirus family inhibitors and methods of use thereof
EP1987717A1 (de) * 2007-04-30 2008-11-05 Bayer CropScience AG Pyridoncarboxamide, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung und deren Verwendung
EP2008996A1 (en) 2007-06-27 2008-12-31 Syngeta Participations AG Process for the production of pyrazoles
AU2009265035B2 (en) * 2008-07-01 2011-12-22 Corteva Agriscience Llc Improved process for the preparation of 2-Trifluoromethyl-5-(1-substituted)alkylpyridines
DK2310350T3 (en) 2008-07-04 2017-12-11 Solvay PROCEDURE FOR THE PREPARATION OF ALKENONES
EP2154167A1 (de) * 2008-07-30 2010-02-17 Bayer MaterialScience AG Elektromechanischer Wandler mit einem Polymerelement auf Polyisocyanat-Basis
KR20160131129A (ko) 2008-09-30 2016-11-15 솔베이(소시에떼아노님) 할로겐화 환형 화합물의 합성 방법
BR112012000279A2 (pt) 2009-07-06 2016-02-23 Solvay processos para preparar e para fabricar um precursor halogenado de uma alquenona, e para preparar uma alquenona
PL2451763T3 (pl) 2009-07-06 2015-08-31 Solvay Sposób wytwarzania halogenowanych prekursorów alkenonów w obecności rozpuszczalnika
US8440865B2 (en) 2009-07-06 2013-05-14 Solvay Sa Process for the manufacture of alkenones
JP6194245B2 (ja) * 2013-12-27 2017-09-06 株式会社Ｓｕｂａｒｕ 信号機認識装置

Also Published As

Publication number Publication date
CN106083710A (zh) 2016-11-09
JP2018058869A (ja) 2018-04-12
WO2010037688A1 (en) 2010-04-08
US8981115B2 (en) 2015-03-17
JP2020023533A (ja) 2020-02-13
CA2735921C (en) 2017-03-21
US20110178297A1 (en) 2011-07-21
KR20190080972A (ko) 2019-07-08
US20130237710A1 (en) 2013-09-12
JP2012504153A (ja) 2012-02-16
KR20160131129A (ko) 2016-11-15
EP2334645B1 (en) 2019-11-06
JP6180705B2 (ja) 2017-08-16
US8431710B2 (en) 2013-04-30
CN106083710B (zh) 2021-03-12
CA2735921A1 (en) 2010-04-08
EP2334645A1 (en) 2011-06-22
CN102164898A (zh) 2011-08-24
JP2022028792A (ja) 2022-02-16
JP6511346B2 (ja) 2019-05-15
JP2015227339A (ja) 2015-12-17
JP6647268B2 (ja) 2020-02-14

Similar Documents

Publication Publication Date Title
JP6647268B2 (ja) ハロゲン化環式化合物の合成方法
MXPA01012485A (es) Dinitrilos de acido arilmalonico sustituidos como intermediarios para la preparacion de herbicidas.
US6462195B1 (en) Methods for highly selectively o-alkylating amide compounds with the use of copper salts
US20100029939A1 (en) Preparation of ketone amides
US6320053B1 (en) Preparation of heteroarylcarboxamides
AU746709B2 (en) Process for the preparation of heteroarylcarboxylic amides and esters
JPH0713063B2 (ja) 新規ジアミン類
US5011927A (en) Preparation of 2-amino-4-fluoropyrimidine derivatives
JP2991832B2 (ja) ピリミジン誘導体の製造方法
JP3085513B2 (ja) ５−クロロ−４−ヒドロキシ−６−メチルピリミジンの製法
CN110352193A (zh) 制备4-[(4,5-二氢-3-甲氧基-4-甲基-5-氧代-1h-1,2,4-三唑-1-基)羰基)氨磺酰基]-5-甲基噻吩-3-甲酸甲酯的方法
JP2008517967A (ja) フェニル２−ピリミジニルケトン類の製造方法及びその新規中間体
CZ289774B6 (cs) Způsob výroby arylamidů heteroaromatických karboxylových kyselin
CZ66299A3 (cs) Syntéza beta-ketoesteru hydrazonu reakcí s diazoesterem
JPH0348905B2 (enExample)
HK1018060B (en) Process for the preparation of heteroarylcarboxylic amides and esters
JPH1077270A (ja) ２−（１−クロロビニル）ピリジン誘導体およびその製造方法
KR20010035293A (ko) 2,6-디클로로-5-플루오로 니코틴산 유도체의 제조방법

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20110429

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20140825

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20151126

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20160808

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20151126

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

A107 Divisional application of patent
AMND Amendment
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20161107

PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20160808

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20160426

Comment text: Amendment to Specification, etc.

PX0601 Decision of rejection after re-examination

Comment text: Decision to Refuse Application

Patent event code: PX06014S01D

Patent event date: 20161129

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20161107

Comment text: Decision to Refuse Application

Patent event code: PX06011S01I

Patent event date: 20160808

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20160426

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20151126